Abstract
Pulmonary arterial hypertension (PAH) is a complex, progressive and fatal vascular lung disease characterized by increased pulmonary artery pressure greater than 25 mmHg. Despite considerable and recent advances in understanding and medical therapy for PAH, the 1-year incident mortality rate of PAH remains high (15%). That is the result of the current therapy may not often recover the sev…